Nigeria

in page functions
[French]
Total population (2015) 183,523,432
Birth cohort (2015) 7,441,169
Surviving Infants (surviving to 1 year per year, 2015) 6,917,430
Infant mortality rate (deaths < 1 year per 1000 births, 2013) 74/1000
Child mortality rate (deaths < 5 years per 1000 births, 2013) 117/1000
World Bank Index, IDA (2012) 3.44
Gross Nation Income (per capita US$, 2013) 2,710
Co-financing status (2013) Intermediate
No. of districts/territories (2013) 774

Gavi support for Nigeria

Type of support

Approvals

2001-2020 (US$)
(31 Dec 2014)

Commitments

2001-2020 (US$)
(31 Dec 2014)

Disbursements

2000-2014 (US$)
(31 Dec 2014)

% Disbursed

(31 Dec 2014)
2001 2002 2003 2004 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Health system strengthening (HSS 1) $44,704,000 $44,704,000 $42,438,758 95%
Immunisation services support (ISS) $47,324,000 $47,324,000 $47,324,000 100%
Injection safety support (INS) $12,630,270 $12,630,270 $12,610,218 100%
IPV (NVS) $14,022,889 $26,897,889 $6,012,559 43%
Measles SIA (NVS) $10,402,870 $10,402,870 $10,402,870 100%
Measles SIA - Operational costs (OPC) $19,290,000 $19,290,000 $19,290,000 100%
Meningitis A - campaign (NVS) $56,878,516 $56,878,516 $56,969,449 100%
Meningitis A - operational costs (OPC) $43,505,648 $43,505,648 $43,505,648 100%
Penta (NVS) $104,235,982 $104,235,982 $69,687,982 67%
Pneumo (NVS) $51,552,000 $51,552,000 $13,621,101 26%
Vaccine Introduction Grant (VIG) $15,862,474 $15,862,474 $6,313,353 40%
Yellow Fever (NVS) $39,012,946 $39,012,946 $40,348,159 103%
Yellow Fever - campaign (NVS) $11,117,819 $34,689,319 $11,117,819 100%
YF - Operational costs (OPC) $6,495,000 $19,017,000 $6,495,000 100%
Total $477,034,414 $526,002,914 $386,136,915

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Nigeria DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence


N/A
DTP3 - Official country estimates (2013) 65%
M:F sex ratio at birth (2015) 1.06
Household survey: DTP3 coverage for male (2013) 39.40%
Household survey: DTP3 coverage for female (2013) 37.00%
Household survey: Last DTP3 survey (2013) 38%
% districts achieving > 80% DTP3 coverage (2013) 72%
% districts achieving < 50% DTP3 coverage (2013) 5%
MCV WHO/UNICEF estimates (2013) 59%
Polio WHO/UNICEF estimates (2013) 67%

Breakdown of support

Non-vaccine support Vaccine support
46% 54%
$177,976,975 $208,159,936

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Nigeria

26 January 2015

Industry and private sector leaders meet with Gavi and Bill Gates ahead of the Replenishment Conference in Berlin, Germany

Private sector makes new pledges to support childhood immunisation in developing countries

Vaccine manufacturers and private firms set out commitments ahead of major Gavi conference

28 October 2014

Nigeria map

Review of Gavi support to Nigeria

Audit of cash support in Nigeria relating to funds disbursed in the period 2011-2013.

18 September 2014

Nepal IPV

Nepal becomes first country to introduce IPV with Gavi support

Nepal is one of 25 countries who have received approval to begin using IPV with Gavi support. Afghanistan and Pakistan are also planning to introduce IPV by end of next year.

close icon

modal window here